AFMsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-03-12
Share capital
50,000.00 PLN
Registered address
Tymiankowa 22, 95-054 Ksawerów, Poland

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 244 days for 2022).

  • 2025not filed
  • 202402/07/2025
  • 202305/02/2025
  • 202215/03/2024
  • 202117/10/2022
  • 202015/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 71%
Sector · Manufacturing17,536 / 24,460
Top 72%
City · Ksawerów45 / 76
Top 59%
Voivodeship · Łódzkie8,214 / 15,300
Top 54%
Country · Poland159,475 / 297,873
Top 54%

Results vs industry

Revenue
This companyUSD 228.10kMedianUSD 919.05kAverageUSD 25.83m
Net profit
This companyUSD 2.28kMedianUSD 14.92kAverageUSD 2.77m
Operating costs
This companyUSD 219.84kMedianUSD 873.06kAverageUSD 21.43m
Assets
This companyUSD 159.10kMedianUSD 897.46kAverageUSD 31.52m

Authorized Representatives

Anna Teresa Kusiak – Vice President of the Management Board
Marek Maciej Bielawski – President of the Management Board

Manner of representation

If a multi-member management board is appointed, the company is represented by each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Marek Maciej Bielawskiage 63
50$6,753.1150%
Anna Teresa Kusiakage 66
50$6,753.1150%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-07-08.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Investment property
PLN 11,945

Public aid

20 public aid cases recorded, with a total value of $46,638.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$598
De minimis aid (in accordance with Commission Regulation 2023/2831)
$242
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,829

Competitors

Name
Aflofarm Farmacja Polskasp. z o.o.
PolfarmexS.A.
Toruńskie Zakłady Materiałów Opatrunkowych Tkalnie ZelówS.A.
Biomarsp. z o.o.
DR Andresp. z o.o.
STEM Cells SpinS.A.
F1 PharmaS.A.
Ti-Comsp. z o.o.
LideoS.A.
Munar PharmaS.A.

FAQ

Last updated: 2026-07-01